Divis Laboratories

Geojit Financial Services recommended reduce rating on Divis Laboratories with a target price of Rs 5400 in its research report dated September 10, 2025.

Accumulate Divis Laboratories; target of Rs 6550: Prabhudas Lilladher

Prabhudas Lilladher recommended accumulate rating on Divis Laboratories with a target price of Rs 6550 in its research report dated August 07, 2025.

Accumulate Divis Laboratories; target of Rs 7518: Deven Choksey

Deven Choksey recommended accumulate rating on Divis Laboratories with a target price of Rs 7518 in its research report dated May 23, 2025.

Reduce Divi's Laboratories: target of Rs 5,610: ICICI Securities

ICICI Securities recommended reduce rating on Divi's Laboratories with a target price of Rs 5,610 in its research report dated May 19, 2025.

Trade Spotlight: How should you trade Tejas Networks, JSW Energy, APL Apollo, Divis Labs, Supreme Industries, Nippon Life, GE Vernova and others on May 20?

The market is likely to consolidate further and may attempt to surpass last Thursday's swing high. Below are some short-term trading ideas to consider.

Divi’s Laboratories shares rally 6% on strong Q4 show; should you buy, sell or hold?

Divi's Labs reported a 23 percent jump in net profit for the three months ended March at Rs 662 crore.

Stocks to Watch Today: Divis Labs, Premier Energies, Delhivery, Dr Reddys, Bharat Electronics, KEC International, Sun Pharma, PNC Infratech in focus on 19 May

Stocks to Watch, 19 May: Stocks like Zen Technologies, Arvind Fashions, Galaxy Surfactants, KRBL, Kalpataru Projects International, IOL Chemicals, Repco Home Finance, CreditAccess Grameen, Dhampur Sugar Mills, Gujarat Alkalies, Kaynes Technology India, Texmaco Rail & Engineering, Sterlite Technologies, and Dr Reddy's Laboratories will be in focus on May 19.

Trade Spotlight: How should you trade Divis Labs, APL Apollo Tubes, UPL, GMR Airports, Jubilant Pharmova, Ceat and others on April 25?

The key indices are likely to consolidate and remain range-bound in the upcoming sessions. Below are some trading ideas for the near term.

Trade Spotlight: How should you trade Kotak Mahindra Bank, Zomato, UPL, BSE, Ashok Leyland, and others on February 20?

The market is expected to gain strength soon amid ongoing range-bound trading. Below are some trading ideas for the near term.

Neutral Divis Laboratories; target of Rs 6200: Motilal Oswal

Motilal Oswal recommended Neutral rating on Divis Laboratories with a target price of Rs 6200 in its research report dated February 03, 2025.

Accumulate Divis Laboratories; target of Rs 6435: KR Choksey

KR Choksey recommended accumulate rating on Divis Laboratories with a target price of Rs 6435 in its research report dated February 05 2025.

Accumulate Divis Laboratories; target of Rs 6250 Prabhudas Lilladher

Prabhudas Lilladher recommended accumulate rating on Divis Laboratories with a target price of Rs 6250 in its research report dated February 04, 2024.

Divi's Labs shares soar 5% as investors cheer solid Q3 earnings

Divi's Labs delivered well rounded earnings growth in Q3, beating expectations on all major parameters--profit, revenue and profitability.

Trade Spotlight: How should you trade IRCTC, Bajaj Finance, Bajaj Auto, Biocon, Redington, Divis Laboratories, and others on January 21?

The market may extend its upward journey, but sustainability is the key to watch, given the elevated volatility. Below are some trading ideas for the near term.

Trade Spotlight: How should you trade Bank of Baroda, EPL, KEC International, Tata Power, Divis Labs, Tata Elxsi, and others on Wednesday?

Overall, the market is likely to remain positive as long as it sustains above all key moving averages. Below are some trading ideas for the near term.

Buy Divis Laboratories; target of Rs 6812: Sharekhan

Sharekhan is bullish on Divis Laboratories has recommended buy rating on the stock with a target price of Rs 6812 in its research report dated November 11, 2024.

Accumulate Divi's Laboratories target of Rs 6000 Prabhudas Lilladher

Prabhudas Lilladher recommended Accumulate rating on Divi's Laboratories with a target price of Rs 6000 in its research report dated November 11, 2024.

Stock Radar: Tata Motors, Asian Paints, Divis Labs, Ola Electric, ITI, Metropolis, DCX Systems, GR Infraprojects in focus on Monday

Stocks like Life Insurance Corporation, Fortis Healthcare, CE Info Systems, Aarti Industries, Welspun Corp, Archean Chemical Industries, Advanced Enzyme Technologies, DCX Systems, JSW Steel and G R Infraprojects will be in focus on November 11.

Analyst Call Tracker: Divi's Labs wins back favour after Nifty 50 departure

While supply chain diversification and the US Biosecure Act can help Divi's target the $800 million revenue opportunity from GLP-1 APIs, many brokerages also warned that these narratives are unlikely to materialise as quickly as investors expect.